Alejandra Delagua, | |
1141 Pear Tree Ln Ste 100, Napa, CA 94558-6485 | |
(707) 254-1770 | |
Not Available |
Full Name | Alejandra Delagua |
---|---|
Gender | Female |
Speciality | Social Worker |
Location | 1141 Pear Tree Ln Ste 100, Napa, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1043863996 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Alejandra Delagua, 1141 Pear Tree Ln Ste 100, Napa, CA 94558-6485 Ph: (707) 254-1776 | Alejandra Delagua, 1141 Pear Tree Ln Ste 100, Napa, CA 94558-6485 Ph: (707) 254-1770 |
News Archive
Galapagos NV announced today that it has started a Phase II clinical study for the Company's flagship program GLPG0259, a novel drug being developed for rheumatoid arthritis. In this clinical trial, the safety and efficacy of this novel candidate drug will be tested in RA patients. Galapagos plans to announce interim results by the middle of next year and complete the trial by the end of 2011.
Green tea, native to China and India, has gained immense popularity for its health benefits. Now, there are more reasons to drink green tea, as scientists found consuming tea at least three times a week could help reduce the risk of premature death, living a longer and healthier life.
A radiologic technology, which functions like a 'human GPS system,' and provides more precise results while using less radiation, is being used to treat patients with symptomatic uterine fibroids exclusively at Paoli Hospital. Dr. Atul Gupta, director of interventional radiology, is treating patients as part of a first-ever clinical trial.
Genetic study results show that long-term kidney transplant rejection risk may be increased if the organ donor has a variant form of the multidrug resistance 1 gene.
› Verified 6 days ago